Division of Research Spotlight
The Kaiser Permanente Division of Research conducts, publishes, and disseminates epidemiologic and health services research to improve the health and medical care of Kaiser Permanente members and society at large. We seek to understand the determinants of illness and well-being, and to improve the quality and cost-effectiveness of health care. Currently, DOR’s 550-plus staff is working on more than 350 epidemiological and health services research projects.
Kaiser Permanente study found Black patients as well as patients who had obesity, liver disease, or sepsis or other signs of infection were among those more likely to be at high risk for a blood clot.
Even if emergency personnel were able to use the best stroke assessment tool available, most patients taken directly by ambulance to a comprehensive stroke center could have been treated at a primary stroke center instead, a new Kaiser Permanente study suggests.
COVID-19 patients who are not hospitalized are at low risk of developing blood clots and should not routinely be prescribed blood thinners, a new Kaiser Permanente research letter suggests.
A sophisticated system that analyzes electronic data about hospital patients, identifies those at risk of deteriorating, and issues an alert to a centralized team of specially trained nurses resulted in a lower mortality rate, Kaiser Permanente researchers reported in the New England Journal of Medicine.
Kaiser Permanente study is the first to compare early telehealth approach to early in-person follow-up to prevent hospital readmissions.
The new Kaiser Permanente study findings support previous research that suggests fear of contracting the novel coronavirus in a medical setting may have kept people from receiving critically needed medical care.
New research by Kaiser Permanente shows the weekly number of patients admitted to Kaiser Permanente Northern California hospitals with acute myocardial infarction (heart attacks) fell to nearly half of what would be expected after the onset of the COVID-19 pandemic.
In the race to find safe and effective treatments for seriously ill patients with COVID-19, Kaiser Permanente Northern California (KPNC) is enrolling patients in nationwide clinical trials and pursuing other innovative treatment options.
A JAMA study, using data on patients hospitalized in March from all 21 Kaiser Permanente Northern California hospitals, is one of the first U.S. studies to look at overall hospitalization admissions of COVID-19 patients.
Kaiser Permanente physician-researcher Vincent Liu, MD, MS, is involved in 3 different studies on sepsis with $4 million in funding from federal and foundation sources.